AXL in metastatic ovarian cancer tumors is a targetable biomarker associated with chemoresistance and poor prognosis

被引：0
|
作者：
Mullen, M. M. [1 ]
Quinn, J. M. [1 ]
Greenwade, M. [2 ]
Opara, G. [1 ]
Beck-Noia, H. [1 ]
Hagemann, I. S. [1 ]
Hagemann, A. R. [1 ]
Kuroki, L. M. [1 ]
McCourt, C. K. [3 ]
Thaker, P. H. [1 ]
Powell, M. A. [1 ]
Mutch, D. G. [1 ]
Fuh, K. C. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
[2] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA
[3] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2019年 / 154卷
关键词：
D O I：
10.1016/j.ygyno.2019.04.188
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1257
引用
收藏
页码：79 / 80
页数：2
相关论文
共 50 条
  • [21] Overexpression of keratin 17 is associated with poor prognosis in epithelial ovarian cancer
    Wang, Ya-Feng
    Lang, Hai-Yang
    Yuan, Jing
    Wang, Jun
    Wang, Rui
    Zhang, Xin-Hui
    Zhang, Jie
    Zhao, Tao
    Li, Yu-Rong
    Liu, Jun-Ye
    Zeng, Li-Hua
    Guo, Guo-Zhen
    TUMOR BIOLOGY, 2013, 34 (03) : 1685 - 1689
  • [22] Plasmacytoid dendritic cells infiltrating ovarian cancer are associated with poor prognosis
    Labidi-Galy, Sana Intidhar
    Treilleux, Isabelle
    Goddard-Leon, Sophie
    Combes, Jean-Damien
    Blay, Jean-Yves
    Ray-Coquard, Isabelle
    Caux, Christophe
    Bendriss-Vermare, Nathalie
    ONCOIMMUNOLOGY, 2012, 1 (03) : 379 - 381
  • [23] AXL Is an Essential Factor and Therapeutic Target for Metastatic Ovarian Cancer
    Rankin, Erinn B.
    Fuh, Katherine C.
    Taylor, Tiffany E.
    Krieg, Adam J.
    Musser, Margaret
    Yuan, Jenny
    Wei, Kevin
    Kuo, Calvin J.
    Longacre, Teri A.
    Giaccia, Amato J.
    CANCER RESEARCH, 2010, 70 (19) : 7570 - 7579
  • [24] TNIK serves as a novel biomarker associated with poor prognosis in patients with pancreatic cancer
    Zhang, Yong
    Jiang, Hongwei
    Qin, Mingfang
    Su, Xiangyu
    Cao, Zhanguo
    Wang, Ju
    TUMOR BIOLOGY, 2016, 37 (01) : 1035 - 1040
  • [25] HES 1 is essential for chemoresistance induced by stellate cells and is associated with poor prognosis in pancreatic cancer
    Cao, Feng
    Li, Jia
    Sun, Haichen
    Liu, Shuang
    Cui, Yeqing
    Li, Fei
    ONCOLOGY REPORTS, 2015, 33 (04) : 1883 - 1889
  • [26] VCAM1 Expression Correlated with Tumorigenesis, Chemoresistance and Poor Prognosis in High Grade Serous Ovarian Cancer
    Huang, J.
    Zhang, J.
    Shan, W.
    Mercado-Uribe, I.
    Liu, J.
    MODERN PATHOLOGY, 2013, 26 : 279A - 280A
  • [27] VCAM1 Expression Correlated with Tumorigenesis, Chemoresistance and Poor Prognosis in High Grade Serous Ovarian Cancer
    Huang, J.
    Zhang, J.
    Shan, W.
    Mercado-Uribe, I.
    Liu, J.
    LABORATORY INVESTIGATION, 2013, 93 : 279A - 280A
  • [28] Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
    Li-yuan Feng
    Bing-bing Yan
    Yong-zhi Huang
    Li Li
    Clinical Epigenetics, 2021, 13
  • [29] Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
    Feng, Li-yuan
    Yan, Bing-bing
    Huang, Yong-zhi
    Li, Li
    CLINICAL EPIGENETICS, 2021, 13 (01)
  • [30] Elevated mRNA Expression Levels of NCAPG are Associated with Poor Prognosis in Ovarian Cancer
    Xu, Tao
    Dong, Menglu
    Wang, Zhi
    Li, Hanning
    Li, Xingrui
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 5773 - 5786
12345